Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
568-04-003 ISMRM Abstract

Bi-parametric quantitative prostate MRI using a single 3D reduced FOV distortion-free sequence

Primary: Body - Prostate
Secondary: Acquisition & Reconstruction - Quantitative Imaging: chest, abdomen, and pelvis
568-04-003 · Prostate: Technical Applications, Sequences, and Coil Development · Wednesday, 13 May, 2:35 PM–3:30 PM · Digital Posters Row I
Keywords: Prostate MRI T2 mapping Reduced field-of-view Diffusion Preparation Distortion-free diffusion
Accepted
Yannik Ott 1,2, Sarah McElroy1,3, Raphael Tomi-Tricot1,4, Carolyn Horst5,6, Rahul Khamar5,6, Omar Darwish2, Vicky J Goh5,6, Radhouene Neji1
1Research Department of Imaging Physics and Engineering, School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom
2Research and Clinical Translation, Magnetic Resonance, Siemens Healthineers AG, Erlangen, Germany
3MR Research Collaborations, Siemens Healthcare Limited, Camberley, United Kingdom
4Siemens Healthcare SAS, Courbevoie, France
5Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom
6Research Department of Cancer Imaging, School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom
Presenting Author: Yannik Ott

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Turkbey B, Rosenkrantz AB, Haider MA, et al. Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. European urology. 2019;76(3):340-351.
2. Twilt JJ, Saha A, Bosma JS, et al. Evaluating biparametric versus multiparametric magnetic resonance imaging for diagnosing clinically significant prostate cancer: an international, paired, noninferiority, confirmatory observer study. European urology. 2025;87(2):240-250.
3. Ng AB, Asif A, Agarwal R, et al. Biparametric vs multiparametric MRI for prostate cancer diagnosis: the PRIME diagnostic clinical trial. JAMA. 2025;334(13):1170-1179.
4. Meyer HJ, Wienke A, Surov A. Discrimination between clinical significant and insignificant prostate cancer with apparent diffusion coefficient–a systematic review and meta analysis. BMC cancer. 2020;20:1-11.
5. Panda A, Obmann VC, Lo WC, et al. MR fingerprinting and ADC mapping for characterization of lesions in the transition zone of the prostate gland. Radiology. 2019;292(3):685-694.
6. Lee CH, Taupitz M, Asbach P, Lenk J, Haas M. Clinical utility of combined T2-weighted imaging and T2-mapping in the detection of prostate cancer: a multi-observer study. Quantitative Imaging in Medicine and Surgery. 2020;10(9):1811.
7. Dinh AH, Souchon R, Melodelima C, et al. Characterization of prostate cancer using T2 mapping at 3 T: a multi-scanner study. Diagnostic and interventional imaging. 2015;96(4):365-372.
8. Cao X, Liao C, Zhou Z, et al. DTI-MR fingerprinting for rapid high-resolution whole-brain T1, T2, proton density, ADC, and fractional anisotropy mapping. Magnetic resonance in medicine. 2024;91(3):987-1001.
9. Ma S, Nguyen CT, Han F, et al. Three-dimensional simultaneous brain T1, T2, and ADC mapping with MR multitasking. Magnetic resonance in medicine. 2020;84(1):72-88.
10. Lee H, Price RR. Diffusion imaging with the MP-RAGE sequence. Journal of Magnetic Resonance Imaging. 1994;4(6):837-842.
11. McElroy S, Tomi-Tricot R, Cleary J, et al. 3D distortion-free, reduced FOV diffusion-prepared gradient echo at 3 T. Magnetic Resonance in Medicine. 2025;93(4):1471-1483.
12. Haase A, Frahm J, Hanicke W, Matthaei D. 1H NMR chemical shift selective (CHESS) imaging. Physics in Medicine & Biology. 1985;30(4):341.
13. Miller KL, Pauly JM. Nonlinear phase correction for navigated diffusion imaging. Magnetic Resonance in Medicine: An Official Journal of the International Society for Magnetic Resonance in Medicine. 2003;50(2):343-353.
14. Captur G, Gatehouse P, Keenan KE, et al. A medical device-grade T1 and ECV phantom for global T1 mapping quality assurance—the T1 Mapping and ECV Standardization in cardiovascular magnetic resonance (T1MES) program. Journal of cardiovascular magnetic resonance. 2016;18(1):58.
15. Biasiolli L, Lindsay AC, Chai JT, Choudhury RP, Robson MD. In-vivo quantitative T2 mapping of carotid arteries in atherosclerotic patients: segmentation and T2 measurement of plaque components. Journal of Cardiovascular Magnetic Resonance. 2013;15(1):69.
16. Bustin A, Lima da Cruz G, Jaubert O, Lopez K, Botnar RM, Prieto C. High-dimensionality undersampled patch-based reconstruction (HD-PROST) for accelerated multi-contrast MRI. Magnetic resonance in medicine. 2019;81(6):3705-3719.

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/568-04-003